Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Penile Neoplasms 1Melanoma 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 11Nivolumab 6Cetuximab 5Gemcitabine 4Filgrastim 4Cisplatin 4Carboplatin 4tislelizumab 3Radiosurgery 3Ipilimumab 3Injections 3Fluorouracil 3Docetaxel 3Cyclophosphamide 3Bortezomib 3toripalimab 2spartalizumab 2poly ICLC 2pazopanib 2entrectinib 2durvalumab 2cemiplimab 2belinostat 2atezolizumab 2Temozolomide 2Surveys and Questionnaires 2Riluzole 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Ganciclovir × Head & Neck × Clear all
NCT05578820 2024-07-01

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Gene Surgery LLC

Phase 1 Completed
21 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Melanoma, Penile Neoplasms, Sarcoma, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡